You're reading the free version. Trader adds the live tape and alerts.
Start tracking
PLX Award Disclosure
Schwartz Aharon · SEC Form 4 · Filed Sep 9, 2026
Award
Calculated transaction value
$0
Schwartz Aharon Director
PLX
Transaction date
Sep 3, 2026
Public filing date
Sep 9, 2026
Filing lag
Filed 6 days later
PLX daily price context
Close on/before transaction
$2.62
Sep 3, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Options (Right to Buy) on Common Stock
- Quantity / price
- 17,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001178913-26-004471
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Protalix Biotherapeutics, Inc. PLX Current | Award | Sep 3, 2026 | $0 |
| Protalix Biotherapeutics, Inc. PLX | Award | Sep 3, 2026 | $0 |